Find the latest Curis, Inc. (CRIS) stock quote, history, news and other vital information to help you with your stock trading and investing. Contact - Curis, Inc Curis Inc 4 Maguire RdLexington, MA 02421(617) email@example.com CRIS Stock Price | Curis Inc. Stock Quote (U ... - MarketWatch CRIS | Complete Curis Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Curis Elects Board Member Jul. 15, 2003 at 12:01 a.m. ET on
Curis, Inc. Common Stock (CRIS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
NASDAQ:CRIS / Curis, Inc. - Stock Price Quote and News CRIS / Curis, Inc. 424B5 - Prospectus - 424B5. 03-06 sec.gov 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-224627 Up to $30,000,000 PROSPECTUS SUPPLEMENT (To Prospectus Dated May 17, 2018) Common Stock We have entered into a Capital on Demand Sales Agreement with JonesTrading Institutional Services LLC, or JonesTrading, relating to shares of our … Curis Stock Chart - CRIS Oct 30, 2019 · Curis (CRIS) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.
Find the latest Institutional Holdings data for Curis, Inc. Common Stock (CRIS) at Nasdaq.com.
Curis, Inc. (CRIS) Stock Forum & Discussion - Yahoo Finance Find the latest Curis, Inc. (CRIS) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.
CRIS Stock Quote - Curis, Inc. Stock Price Today Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170, and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes.
CRIS Stock | Message Board | Curis Inc. - Investors Hangout
CRIS Price Target and Analyst Ratings (Curis) | MarketBeat Nov 05, 2019 · Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. CRIS, Curis (formerly CBMI) | Stock Discussion Forums
View the latest Curis Inc. (CRIS) stock price, news, historical charts, analyst ratings and financial information from WSJ. Latest Curis Inc (CRIS) Headlines Curis - CRIS Curis Inc ... Latest Curis Inc (CRIS) Headlines Curis to Present at the 26th Annual ROTH Conference GlobeNewswire - Tue Mar 04, 6:11AM CST Curis, Inc. (Nasdaq:CRIS), an oncology-focused company developing novel, targeted drug candidates for the treatment of human cancers, today announced that the Company will present at the 26 Annual ROTH Conference at 8:30 a.m. PT on March 11, 2014, in Laguna Niguel, CA. Curis Historical Data - CRIS | ADVFN Aug 11, 2019 · Curis historical price data and CRIS charts. Free real-time prices, trades, and chat. Curis (CRIS) stock price, charts, trades & the US's most popular discussion forums.